Fund Holdings — Paradigm Biocapital Advisors LP

Total Portfolio Value:
$3.73B
Total Bought:
$953.49M
Total Sold:
$1.12B
Net Transaction:
-$162.02M
Notable People:
Dr. Senai Nmn Asefaw
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Nuvalent Inc5,269,4335,269,4330$455.70M$530.05M14.19%+$74.35M
Revolution Medicines, Inc.(RVMD)6,223,2916,644,403+421,112$290.63M$529.23M14.17%+$238.60M
Arcellx Inc
COMMON STOCK
4,649,0165,724,016+1,075,000$381.68M$373.21M9.99%-$8.48M
Genmab A/SADS(GMAB)3,816,8517,039,834+3,222,983$117.06M$216.83M5.81%+$99.76M
Tarsus Pharmaceuticals, Inc.(TARS)2,665,6982,562,154-103,544$158.42M$209.79M5.62%+$51.37M
ABIVAX Société AnonymeADS(ABVX)1,564,1961,417,473-146,723$132.80M$191.15M5.12%+$58.35M
Olema Pharmaceuticals, Inc.(OLMA)6,794,1727,544,172+750,000$66.51M$188.60M5.05%+$122.09M
Vaxcyte, Inc.(PCVX)3,784,7554,068,020+283,265$136.33M$187.70M5.03%+$51.37M
Cidara Therapeutics Inc961,164759,565-201,599$92.04M$167.78M4.49%+$75.74M
Edgewise Therapeutics, Inc.(EWTX)6,170,1316,541,210+371,079$100.08M$162.32M4.35%+$62.24M
Scholar Rock Holding Corporation(SRRK)2,009,7453,062,157+1,052,412$74.84M$134.89M3.61%+$60.05M
UroGen Pharma Ltd.(URGN)4,216,0844,473,648+257,564$84.11M$104.77M2.81%+$20.66M
Crinetics Pharmaceuticals In2,550,7742,210,774-340,000$106.24M$102.91M2.76%-$3.33M
Apogee Therapeutics Inc1,521,7571,123,243-398,514$60.46M$84.78M2.27%+$24.32M
EyePoint, Inc.(EYPT)2,005,3653,691,475+1,686,110$28.56M$67.44M1.81%+$38.89M
Erasca, Inc.(ERAS)13,560,01714,159,095+599,078$29.56M$52.67M1.41%+$23.11M
BridgeBio Pharma, Inc.(BBIO)684,277684,2770$35.54M$52.34M1.40%+$16.80M
Oruka Therapeutics, Inc.(ORKA)01,710,316+1,710,316$0$51.84M1.39%+$51.84M
Spyre Therapeutics, Inc.(SYRE)1,467,2661,467,2660$24.59M$48.07M1.29%+$23.48M
Lexeo Therapeutics, Inc.(LXEO)04,763,198+4,763,198$0$47.30M1.27%+$47.30M
Viridian Therapeutics, Inc.(VRDN)2,609,3531,443,102-1,166,251$56.31M$44.91M1.20%-$11.40M
Ocular Therapeutix, Inc.(OCUL)3,497,3072,935,284-562,023$40.88M$35.63M0.95%-$5.25M
Terns Pharmaceuticals Inc0810,286+810,286$0$32.74M0.88%+$32.74M
BridgeBio Oncology Therapeutics, Inc.(BBOT)1,866,1412,261,749+395,608$21.61M$28.32M0.76%+$6.71M
Vor Biopharma Inc.(VOR)01,750,000+1,750,000$0$22.89M0.61%+$22.89M
Assembly Biosciences Inc0665,251+665,251$0$22.63M0.61%+$22.63M
ORIC Pharmaceuticals, Inc.(ORIC)02,401,217+2,401,217$0$19.64M0.53%+$19.64M
Inventiva S.A.ADS(IVA)04,000,000+4,000,000$0$18.60M0.50%+$18.60M
Kalaris Therapeutics, Inc.(KLRS)0700,000+700,000$0$5.91M0.16%+$5.91M
Agios Pharmaceuticals, Inc.(AGIO)2,673,5550-2,673,555$107.32M$0—-$107.32M
Alkermes plcSHS(ALKS)1,719,3340-1,719,334$51.58M$0—-$51.58M
Amylyx Pharmaceuticals, Inc.(AMLX)1,900,0000-1,900,000$25.82M$0—-$25.82M
Cogent Biosciences, Inc.(COGT)3,156,3980-3,156,398$45.33M$0—-$45.33M
Disc Medicine, Inc.(IRON)247,7160-247,716$16.37M$0—-$16.37M
Dyne Therapeutics, Inc.(DYN)1,898,9500-1,898,950$24.02M$0—-$24.02M
Janux Therapeutics, Inc.(JANX)2,920,2580-2,920,258$71.37M$0—-$71.37M
LENZ Therapeutics, Inc.(LENZ)1,073,4610-1,073,461$50.00M$0—-$50.00M
Merus N V4,373,7700-4,373,770$411.79M$0—-$411.79M
Pharvaris N V
COM
1,835,4940-1,835,494$45.80M$0—-$45.80M
Structure Therapeutics IncADS372,8690-372,869$10.44M$0—-$10.44M
Tango Therapeutics, Inc.(TNGX)3,086,1840-3,086,184$25.92M$0—-$25.92M
Page 1 of 1
Paradigm Biocapital Advisors LP — 13F Holdings — Q4 2025 | TickerTrail